"10.1371_journal.pone.0045409","plos one","2012-10-01T00:00:00Z","Rotem Orbach; Zhenming Zhao; Yong-Cheng Wang; Gilmore Oâ€™Neill; Diego Cadavid","MS Clinical Development Group, Biogen Idec, Cambridge, Massachusetts, United States of America; Biostatistics, Biogen Idec, Cambridge, Massachusetts, United States of America; Multiple Sclerosis Center at Sheba Medical Center, Tel-Hashomer, Israel","Conceived and designed the experiments: RO ZZ YCW GO DC. Performed the experiments: RO ZZ DC. Analyzed the data: RO ZZ DC. Contributed reagents/materials/analysis tools: YCW GO. Wrote the paper: RO ZZ DC.","GO and DC are full time paid employees and own stock and/or stock options in Biogen Idec. JZ and YCW were full time paid employees of Biogen Idec. RO was a paid Intern at Biogen Idec. Biogen Idec was the sponsor of the IMPACT study and together with Genentech (now a subsidiary of the Roche group) of the OLYMPUS study. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Rotem Orbach","RO",5,TRUE,5,3,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
